Long term maintenance of neural tube defects prevention in a high prevalence state

Journal of Pediatrics

Volumn 159, Issue 1, 2011, Pages

  Collins, Julianne S ^a   Atkinson, Kristy K ^a   Dean, Jane H ^a   Best, Robert G ^b   Stevenson, Roger E ^a  

^a GREENWOOD GENETIC CENTER   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; DISEASE SURVEILLANCE; FEMALE; FETUS; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RECURRENT DISEASE; UNITED STATES; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 79958732147     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.12.037     Document Type: Article

References (28)

1. Rampersaud E, Melvin EC, Speer MC. Nonsyndromic neural tube defects: genetic basis and genetic investigations. In: Wyszynski DF, ed. Neural tube defects, from origin to treatment. New York: Oxford University Press; 2006. p. 165-75.
2. Hunter AGW. Brain and spinal cord. In: Stevenson RE, Hall JG, eds. Human malformations and related anomalies. 2nd ed. New York: Oxford University Press; 2006. p. 715-55.
3. Davis BE, Daley CM, Shurtleff DB, Duguay S, Seidel K, Loeser JD, et al. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg 2005;41:186-91. (Pubitemid 41160218)
4. Locken MR. Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am J Med Genet C 2005;135C:77-87.
5. Higginbottom MC, Jones KL, Hall BD, Smith DW. The amniotic band disruption complex: timing of amniotic rupture and variable spectra of consequent defects. J Pediatr 1979;95:544-9. (Pubitemid 9247430)
6. James WH. Twinning and anencephaly. Ann Hum Biol 1976;3:401-9.
7. Greene NDE, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet 2009;18:R113-9.
8. Smithells RW. Neural tube defects: prevention by vitamin supplements. Pediatrics 1982;69:498-9. (Pubitemid 12135959)
9. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338: 131-7.
10. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-5. (Pubitemid 23003073)
11. Greenberg F, James LM, Oakley GP. Estimates of birth prevalence rates of spina bifida in the United States from computer-generated maps. Am J Obstet Gynecol 1983;145:570-3. (Pubitemid 13149414)
12. Allen WP, Stevenson RE, Thompson SJ, Dean JH. The impact of prenatal diagnosis on NTD surveillance. Prenat Diag 1996;16:531-5. (Pubitemid 26187703)
13. Stevenson RE, Allen WP, Pai GS, Best R, Seaver LH, Dean J, et al. Decline in prevalence of neural tube defects in high-risk region of the United States. Pediatrics 2000;106:677-83.
14. Stevenson RE, Seaver LH, Collins JS, Dean JH. Neural tube defects and associated anomalies in South Carolina. Birth Defects Res A Clin Mol Teratol 2004;70:554-8. (Pubitemid 39244255)
15. Centers for Disease Control and Prevention. Use of folic acid prevention of spina bifida and other neural tube defects - 1983-1991.MMWR1991; 40:513-6.
16. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41:1-7.
17. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996;61:871.
18. SC Department of Health and Environmental Control. 2007 Birth certificate data. Available at: http://scangis.dhec.sc.gov/scan/bdp/tables/birthtable.aspx. Accessed Jan 29, 2010.
19. National Birth Defects Prevention Network. Prevalence of spina bifida and anencephaly before and after folic acid fortification, NBDPN Neural Tube Defect Ascertainment Project; 1995-2005. Available at: http://www.nbdpn.org/current/ resources/ntd-fa-info.html. Accessed Jan 29, 2010.
20. Boulet SL, Yang Q, Mai C, Kirby RS, Collins JS, Robbins JM, et al. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol 2008;82:527-32. (Pubitemid 352032357)
21. Grosse S, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol Teratol 2007;79: 737-42. (Pubitemid 350271820)
22. Collins JS, Canfield MA, Pearson K, Kirby RS, Case AP, Mai CT, et al. Public health projects for preventing the recurrence of neural tube defects in the United States. Birth Defects Res A Clin Mol Teratol 2009; 85:935-8.
23. Andres R, Bixler D. Anencephaly with facial duplications. J Craniofac Genet Dev Biol 1981;1:245-52.
24. Rogers RC. SN (GGC-8217) 23-month-old white male. ProcGreenwood Genet Center 1988;7:55.
25. Ravine D, Ragge NK, Stephens D, Oldrige M, Wilkie AO. Dominant coloboma-microphthalmia syndrome associated with sensorineural hearing loss, hematuria and cleft lip/palate. Am J Med Genet 1997;72: 227-36. (Pubitemid 27426092)
26. Peters HL, Bankier A. Lipomatous meningomyelocele, athyrotic hypothyroidism, and sensorineural deafness: a new form of syndromal deafness? J Med Genet 1998;35:948-50. (Pubitemid 28486625)
27. Martinez-Frias ML, Frias JL, Bermejo E, Rodriguez-Pinilla E, Urioste M. Epidemiological analysis of the schisis association in the Spanish registry of congenital malformations. Am J Med Genet 1997;70:16-23. (Pubitemid 27183870)
28. al-Gazali LI, al-Shather WA. Anterior encephalocele and anophthalmia. Clin Dysmorphol 1996;5:81-3.